|
Munarriz D, Lopez-Godino O, Martinez-Cibrian N, Albiol N, Brillembourg H, Navarro-Velazquez S, Espanol-Rego M, Casanueva S, Garcia-Tomas L, Munoz-Sanchez G, Alserawan L, Benitez-Ribas D, Magnano L, Correa JG, Rivero A, Mozas P, Gine E, Rodriguez-Lobato LG, Martinez-Roca A, Montoro-Lorite M, Ayora P, Esteve J, Frutos L, Balague-Ponz O, Urbano-Ispizua A, Gonzalez-Navarro EA, Juan M, Delgado J, Ortiz-Maldonado V. Combining CAR T-Cell Therapy and Nivolumab to Overcome Immune Resistance in THRLBCL: A Case Report. Int J Mol Sci. 2025 Sep 23;26(19):9265. doi: 10.3390/ijms26199265. PubMed PMID: 41096533; PubMed Central PMCID: PMC12524146.
AÑO: 2025; IF: 4.9
|
41096533